According to Merck's latest financial reports the company's current earnings (TTM) are $3.03 B. a decrease over its 2022 earnings that were of $17.40 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $3.03 B | -82.56% |
2022 | $17.40 B | 18.52% |
2021 | $14.68 B | 80.8% |
2020 | $8.12 B | -34.26% |
2019 | $12.35 B | 30.45% |
2018 | $9.47 B | 30.2% |
2017 | $7.27 B | 35.93% |
2016 | $5.35 B | -11.87% |
2015 | $6.07 B | -66.29% |
2014 | $18.01 B | 183.88% |
2013 | $6.34 B | -32.87% |
2012 | $9.45 B | 17.32% |
2011 | $8.05 B | 240.11% |
2010 | $2.36 B | -84.96% |
2009 | $15.74 B | 66.09% |
2008 | $9.48 B | 68.8% |
2007 | $5.61 B | 52.38% |
2006 | $3.68 B | -37.16% |
2005 | $5.86 B | -11.41% |
2004 | $6.62 B | -20.89% |
2003 | $8.37 B | -11.74% |
2002 | $9.48 B | -2.51% |
2001 | $9.72 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 459.21% | ๐บ๐ธ USA |
Novartis NVS | $9.43 B | 210.97% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | 7.64% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $6.66 B | 119.57% | ๐บ๐ธ USA |
Eli Lilly LLY | $6.55 B | 115.97% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | 158.81% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | 176.62% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $8.44 B | 178.09% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | 148.27% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $0.40 B | -86.66% | ๐ฎ๐ฑ Israel |